tiprankstipranks
Cytosorbents Corp (CTSO)
NASDAQ:CTSO

Cytosorbents (CTSO) Financial Statements

457 Followers

Cytosorbents Financial Overview

Cytosorbents's market cap is currently ―. The company's EPS TTM is $-0.584; its P/E ratio is -1.80; Cytosorbents is scheduled to report earnings on July 30, 2024, and the estimated EPS forecast is $-0.09. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 9.79M$ 7.35M$ 8.81M$ 9.42M-
Gross Profit$ 6.57M$ 3.99M$ 5.61M$ 6.02M$ -3.99M
EBIT$ -6.36M$ -9.34M$ -9.19M$ -6.15M$ -7.34M
EBITDA$ -5.91M$ -8.55M$ -8.73M$ -5.70M$ -7.02M
Net Income Common Stockholders$ -6.36M$ -5.83M$ -9.19M$ -6.15M$ -7.33M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 8.61M$ 14.13M$ 8.36M$ 13.15M$ 19.05M
Total Assets$ 47.07M$ 53.26M$ 47.58M$ 52.44M$ 57.46M
Total Debt$ 17.61M$ 18.31M$ 18.04M$ 18.11M$ 13.17M
Net Debt$ 9.00M$ 4.18M$ 9.68M$ 4.96M$ -5.88M
Total Liabilities$ 28.14M$ 29.99M$ 29.06M$ 28.35M$ 28.51M
Stockholders Equity$ 18.93M$ 23.28M$ 18.51M$ 24.09M$ 28.96M
Cash Flow-
Free Cash Flow$ -4.96M$ -6.54M$ -5.46M$ -6.79M$ -3.79M
Operating Cash Flow$ -4.83M$ -6.41M$ -5.21M$ -6.93M$ -3.11M
Investing Cash Flow$ -127.02K$ -135.92K$ -257.71K$ 140.28K$ -682.88K
Financing Cash Flow$ -571.76K$ 12.21M$ 648.32K$ 931.12K$ 684.28K
Currency in USD

Cytosorbents Earnings and Revenue History

Cytosorbents Debt to Assets

Cytosorbents Cash Flow

Cytosorbents Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis